Annual Drug Patent Expirations for TYVASO+DPI
Tyvaso Dpi is a drug marketed by United Therap and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
Drug patent litigation for TYVASO DPI.
This drug has one hundred and thirty-two patent family members in twenty countries.
The generic ingredient in TYVASO DPI is treprostinil. One supplier is listed for this compound. Additional details are available on the treprostinil profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
